CenturyLink, Inc., a United States of America based Company, belongs to Technology sector and Telecom Services - Domestic industry. Comparatively, Walgreens Boots Alliance, Inc. posted earnings of $0 per share in the same quarter past year. CI Global Investments Inc. now owns 5,931,592 shares of the pharmacy operator's stock valued at $464,503,000 after acquiring an additional 270,182 shares during the last quarter.
Past 5 years growth of WBA observed at 9.40%, and for the next five years the analysts that follow this company is expecting its growth at 15.40%. Wellington Management Group LLP now owns 32,846,862 shares of the pharmacy operator's stock worth $2,727,932,000 after purchasing an additional 1,824,300 shares during the period. Renaissance Technologies LLC now owns 648,000 shares of the pharmacy operator's stock worth $54,588,000 after buying an additional 114,800 shares in the last quarter. If you are accessing this article on another site, it was illegally copied and reposted in violation of United States and worldwide copyright legislation.
Now we will discuss the financial strength of Walgreens Boots Alliance, Inc. That's a potential 22.21 gain from where (NASDAQ:WBA) has been trading recently. A 5 analysts rate it as either a buy or a strong buy, while0 believe that investors should either steer clear of UTX or, if they already own its stock, sell it. Analysts' mean recommendation for the stock is 3.00 (A rating of less than 2 means buy, "hold" within the 3 range, "sell" within the 4 range, and "strong sell" within the 5 range). Mizuho maintained Walgreens Boots Alliance Inc (NASDAQ:WBA) rating on Tuesday, October 24.
The forward P/E of Walgreens Boots Alliance, Inc.is at 11.72 signifying the uses of estimated net earnings over the next 12 months.
Shares of New York-listed Walgreens Boots Alliance (NASDAQ:WBA) Have been downgraded by analysts at Leerink Swann. They noted that the move was a valuation call. Jefferies Group LLC restated a "buy" rating and set a $95.00 target price on shares of Walgreens Boots Alliance in a report on Thursday, September 7th. The company now has an average rating of Buy and a consensus target price of $90.66. During the last 52 weeks, the price has been as high as $88 and as low as $63.82. Quick and current ratio is valued at 0.6 and 1.1 respectively. The company had a trading volume of 12,380,900 shares, compared to its average volume of 10,200,832. Currently, Walgreens Boots Alliance, Inc.net profit margin for the 12 months is at 3.46%. Short-term as well long term investors always focus on the liquidity of the stocks so for that concern, liquidity measure in recent quarter results of the company was recorded 0.80 as current ratio and on the opponent side the debt to equity ratio was - and long-term debt to equity ratio also remained 0.00. With the constructive P/E value of Walgreens Boots Alliance, Inc., the investors are able to forecast the positive earnings growth of the company. (WBA) reported earning per shares for the quarter ending Oct 25 BMO at 1.31, whereas, 19 number of analysts estimated the mean EPS at 1.21. Analysts are forecasting earnings of $1.26 on a per share basis this quarter. Walgreens Boots Alliance's revenue for the quarter was up 5.3% compared to the same quarter last year. research analysts anticipate that Walgreens Boots Alliance, Inc. will post 5.55 earnings per share for the current year. Stockholders of record on Monday, November 13th will be paid a dividend of $0.40 per share. The first value is calculated by adding the dividend yield to the percentage of repurchased shares. The ex-dividend date is Tuesday, November 15th. Walgreens Boots Alliance's dividend payout ratio (DPR) is 42.33%. The company has a market cap of $71,667.88, a PE ratio of 13.92, a P/E/G ratio of 1.26 and a beta of 1.20. In the capital asset pricing model, beta risk is the only kind of risk for which investors should receive an predictable return higher than the risk-free rate of interest. A ratio of under 1 typically indicates that the shares are undervalued. (NASDAQ: WBA) has grabbed attention from the analysts when it experienced a change of 2.09% in the last trading session to close at $70.99.
Relative trade-off between the price of a stock and the earnings prospects stands at 1.22 times. Also, Director John Anthony Lederer acquired 20,000 shares of the firm's stock in a transaction on Thursday, October 26th. The Beta for the company stands at 1.18 and its Average True Range (ATR) shows a value of 1.87. Companies may issue new shares and buy back their own shares. The disclosure for this purchase can be found here. The Firm is a pharmacy-led health and wellbeing company. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale.